Europe’s medicines watchdog on Monday approved a COVID-19 jab by US-based Novavax, which uses a more conventional technology that the biotech firm hopes will reduce vaccine hesitancy.
Read the latest updates in our dedicated coronavirus section.
“EMA has recommended granting a conditional marketing authorization for Novavax’s COVID-19 vaccine Nuvaxovid to prevent COVID-19 in people from 18 years of age,” the European Medicines Agency said of the jab, the fifth to be recommended for authorization in the European Union.
Read more:
Thousands stage peaceful protest in Brussels against COVID-19 restrictions
Saudi Arabia makes COVID-19 booster shot available three months after second dose
Israel to ban travel to US, Canada over omicron variant
